According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is $8.06. In 2021 the company made an earnings per share (EPS) of $15.87 an increase over its 2020 EPS that were of $10.60.
Year | EPS | Change |
---|---|---|
2022 (TTM) | $8.06 | -49.21% |
2021 | $15.87 | 49.72% |
2020 | $10.60 | 66.67% |
2019 | $6.36 | 18% |
2018 | $5.39 | -4.26% |
2017 | $5.63 | 23.19% |
2016 | $4.57 | -7.11% |
2015 | $4.92 | 28.46% |
2014 | $3.83 | -31.61% |
2013 | $5.60 | 60.46% |
2012 | $3.49 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() LabCorp LH | $13.93 | 72.83% | ๐บ๐ธ USA |
![]() Psychemedics PMD | -$0.36 | -104.47% | ๐บ๐ธ USA |
![]() NeoGenomics
NEO | -$1.16 | -114.39% | ๐บ๐ธ USA |
![]() Qiagen QGEN | $1.85 | -77.05% | ๐ณ๐ฑ Netherlands |
![]() Enzo Biochem ENZ | -$0.60 | -107.44% | ๐บ๐ธ USA |